Tango Therapeutics (NASDAQ:TNGX) Shares Up 6.3%

Shares of Tango Therapeutics Inc (NASDAQ:TNGX) shot up 6.3% during mid-day trading on Thursday . The stock traded as high as $14.80 and last traded at $14.80. 1,619 shares traded hands during trading, a decline of 98% from the average session volume of 85,800 shares. The stock had previously closed at $13.92.

A number of research analysts recently weighed in on the stock. Wedbush assumed coverage on shares of Tango Therapeutics in a research note on Tuesday, September 7th. They issued an “outperform” rating on the stock. SVB Leerink started coverage on shares of Tango Therapeutics in a report on Monday, September 20th. They issued an “outperform” rating for the company. Guggenheim initiated coverage on shares of Tango Therapeutics in a report on Tuesday, September 7th. They issued a “buy” rating and a $16.00 price objective for the company. Finally, The Goldman Sachs Group initiated coverage on shares of Tango Therapeutics in a report on Tuesday, September 7th. They set a “buy” rating and a $17.00 price target for the company.

The company has a 50-day moving average of $13.48.

About Tango Therapeutics (NASDAQ:TNGX)

Tango Therapeutics Inc is a biotechnology company. It focused on discovering and delivering precision cancer medicines. Tango Therapeutics Inc, formerly known as BCTG Acquisition Corp., is based in CAMBRIDGE, Mass.

See Also: Strangles

Receive News & Ratings for Tango Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tango Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.